Comment on "Cardio-ankle vascular index as a screening tool for coronary artery disease in patients with metabolic dysfunction-associated steatotic liver disease" [0.03%]
对代谢功能障碍相关肝脂变性疾病患者中应用心血管踝臂指数筛查冠心病的评论
Kanishka Harariya,Thakur Rohit Singh,Ankita Kalra et al.
Kanishka Harariya et al.
Transcatheter pulmonary valve implantation in patients with repaired tetralogy of Fallot: International evidence and the current status in Japan [0.03%]
法洛四联症外科术后肺动脉瓣狭窄的经导管介入治疗：国际进展和日本现状
Tomohito Kogure,Kei Inai,Junichi Yamaguchi
Tomohito Kogure
In repaired tetralogy of Fallot (TOF), chronic pulmonary regurgitation drives right ventricular (RV) dilation, ventricular arrhythmias, and heart failure. Surgical pulmonary valve replacement improves outcomes but requires redo sternotomy. ...
The effect of bedtime vs. morning antihypertensive treatment on cardiovascular events: A Meta-analysis [0.03%]
降压治疗时间对心血管事件影响的荟萃分析研究BEDTIME与晨起服用高血压药哪种效果更好？
Yuriko Hiruma,Tomonari M Shimoda,Atsuyuki Watanabe et al.
Yuriko Hiruma et al.
Background: Antihypertensive medications are essential for preventing cardiovascular events and have traditionally been taken in the morning. However, recent studies have suggested that taking the medication at bedtime ma...
Clinical outcomes and optical coherence tomography findings in myocardial infarction patients without standard modifiable risk factors: Insights from the TACTICS registry [0.03%]
无标准可改变危险因素的心肌梗死患者的临床结果和光学相干层析成像特征：来自TACTICS注册研究的启示
Hideki Wada,Tomotaka Dohi,Manabu Ogita et al.
Hideki Wada et al.
Background: Patients with coronary artery disease who lack any standard modifiable cardiovascular risk factors (SMuRFs; hypertension, diabetes mellitus, dyslipidemia, and smoking) have attracted much attention in recent y...
Beta-Blocker Therapy for Acute Myocardial Infarction with Preserved Ejection Fraction: A Meta-Analysis from Randomized Controlled Trials [0.03%]
射血分数保留的急性心肌梗死患者使用β受体阻滞剂治疗的 meta 分析：随机对照试验结果
Yuriko Hiruma,Atsuyuki Watanabe,Tadao Aikawa et al.
Yuriko Hiruma et al.
Background: Immediate administration of beta-blockers is recommended for acute myocardial infarction (AMI). However, the benefit of beta-blockers according to left ventricular ejection fraction (LVEF), especially for pres...
Cardiac regeneration: The present state and future direction of human pluripotent stem cell therapy [0.03%]
心脏再生：人多能干细胞治疗的现状和未来方向
Tomohiko C Umei,Shugo Tohyama
Tomohiko C Umei
Cardiac regenerative medicine is an emerging field that aims to revolutionize the treatment of heart disease through innovative therapies and technologies. This review highlights the key advancements in human induced pluripotent stem cell (...
Therapeutic ultrasound for acute myocardial infarction: Mechanisms, preclinical evidence, and clinical perspectives [0.03%]
治疗性超声在急性心肌梗死中的作用：机制、前期证据和临床前景
Yosuke Katayama,Koya Ozawa,Tomoko Negishi et al.
Yosuke Katayama et al.
ST-segment elevation myocardial infarction remains a leading cause of mortality. Despite the success of primary percutaneous coronary intervention (PCI), outcomes have plateaued, largely due to reperfusion injury and subsequent microvascula...
Comment on "the impact of large v-waves of pulmonary artery wedge pressure in patients with wild-type transthyretin amyloid cardiomyopathy" [0.03%]
关于“野生型转甲状腺素蛋白淀粉样变性心肌病患者肺动脉楔压大v波的影响”的评论
Bhumesh Tyagi,Leelabati Toppo,Aishwarya Biradar
Bhumesh Tyagi
Ryoichi Ohara,Fumiko Nakatsu,Kazuma Iekushi et al.
Ryoichi Ohara et al.
Background: Our previous multivariable analysis of hypertensive participants in Hiratsuka City identified younger age, grade I hypertension, absence of prior hypertension at the previous specific health check-up (SHC), an...